Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)
A Chanan-Khan; M Egyed; T Robak; Martinelli FA de Oliveira; M A Echeveste; S Dolan; P Desjardins; J Z Blonski; J Mei; N Golany; J Zhang; J G Gribben
Author Information: Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA;
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.